Bill > S977

This bill, titled the "End Taxpayer Funding of Gender Experimentation Act of 2025," aims to comprehensively prohibit federal funding for gender transition procedures across multiple domains of government healthcare. The bill defines gender transition procedures extremely broadly, including hormonal treatments, surgical interventions, and various cosmetic procedures related to gender affirmation. It prevents federal funds from being used for such procedures in any federally-owned healthcare facilities, by federal employees, or through federally subsidized health insurance plans, including those under the Affordable Care Act (ACA). While the bill strictly prohibits federal funding for these procedures, it does allow individuals or entities to purchase separate coverage for gender transition procedures using entirely non-federal funds. The legislation also provides some narrow exceptions for medical treatments related to disorders of sex development, life-threatening conditions, or specific medical complications. Additionally, the bill modifies the tax code to disallow premium credits and small employer health insurance credits for plans that include gender transition procedure coverage. The definitions in the bill emphasize biological sex based on reproductive systems, and the provisions would apply to taxable years beginning one year after the act's enactment.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/977/all-info